Allergen-specific immunotherapy in pet allergy - An update;Aktueller Stand der spezifischen Immuntherapie mit Tierepithelien

Hautarzt

Volumn 62, Issue 9, 2011, Pages 657-662

  Raap, U ^a   Wagenmann, M ^b   Pfaar, O ^c  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Allergen specific immunotherapy; Allergic asthma; Animal dander; Cat dander; Rhinitis, allergic

Indexed keywords

ALLERGEN; IMMUNOMODULATING AGENT;

ALLERGIC ASTHMA; ALLERGIC RHINITIS; ARTICLE; CAT; DANDER; DOG; HOUSEHOLD; HUMAN; IMMUNOTHERAPY;

ADMINISTRATION, SUBLINGUAL; ADULT; ANIMALS; CATS; CHILD; DESENSITIZATION, IMMUNOLOGIC; EPITHELIUM; EPITOPES; GLYCOPROTEINS; HUMANS; IMMUNE TOLERANCE; INJECTIONS, SUBCUTANEOUS; PETS; RHINITIS, ALLERGIC, PERENNIAL;

EID: 80052650650     PISSN: 00178470     EISSN: 14321173     Source Type: Journal    
DOI: 10.1007/s00105-011-2159-0     Document Type: Article

References (33)

1. Heutelbeck ARR (2005) Präventaion allergischer Atemwegserkrankungen durch Katzenallergene. Allergo J 14:190-197
2. Schafer T, Wolke G, Ring J et al (2007) Allergic sensitization to cat in childhood as major predictor of incident respiratory allergy in young adults. Allergy 62(11):1282-1287 (Pubitemid 47537499)
3. Maniu CM, Hunezlmann N, Schuster JC (2008) Katzenallergie: aktualisierte Datenlage zu Epidemiologie und Therapie und Neues aus der Molekularbiologie von Feld 1. Allergo J 10(31):410-421
4. Enberg RN, Shamie SM, McCullough J, Ownby DR (1993) Ubiquitous presence of cat allergen in cat-free buildings: probable dispersal from human clothing. Ann Allergy 70(6):471-474 (Pubitemid 23178502)
5. Wentz PE, Swanson MC, Reed CE (1990) Variability of cat-allergen shedding. J Allergy Clin Immunol 85(1 Pt 1):94-98 (Pubitemid 20058888)
6. Charpin C, Zielonka TM, Charpin D et al (1994) Effects of castration and testosterone on Fel dI production by sebaceous glands of male cats: II -Morphometric assessment. Clin Exp Allergy 24(12):1174-1178 (Pubitemid 24380356)
7. Wallace DV (2009) Petdander and perennial allergic rhinitis: therapeutic options. Allergy Asthma Proc 30(6):573-583
8. Avner DB, Perzanowski MS, Platts-Mills TA, Wood-folk JA (1997) Evaluation of different techniques for washing cats: quantitation of allergen removed from the cat and the effect on airborne Fel d 1. J Allergy Clin Immunol 100(3):307-312 (Pubitemid 27402771)
9. Fahlbusch B, Gehring U, Richter K et al (2002) Predictors of cat allergen (Feld 1) in house dust of German homes with/without cats. J Investig Aller-gol Clin Immunol 12(1):12-20 (Pubitemid 34507060)
10. Pfaar O, Klimek L (2008) Specific immunotherapy for allergic rhinitis. Current methods and innovative developments. HNO 56(8):764-775
11. Varney VA, Edwards J, Tabbah K et al (1997) Clinical efficacy of specific immunotherapy to cat dander: a double-blind placebo-controlled trial. Clin Exp Allergy 27(8):860-867 (Pubitemid 27359850)
12. Ohman JLJr, Findlay SR, Leitermann KM (1984) Immunotherapy in cat-induced asthma. Double-blind trial with evaluation of in vivo and in vitro responses. J Allergy Clin Immunol 74(3 Pt 1):230-239 (Pubitemid 14038793)
13. Taylor WW, Ohman JLJr, Lowell FC (1978) Immunotherapy in cat-induced asthma. Double-blind trial with evaluation of bronchial responses to cat allergen and histamine. J Allergy Clin Immunol 61 (5):283-287 (Pubitemid 8335637)
14. Van MTJr, Marsh DG, Adkinson NF Jr et al (1988) Immunotherapy for cat asthma. J Allergy Clin Immunol 82(6):1055-1068 (Pubitemid 19026369)
15. Hedlin G, Graff-Lonnevig V, Heilborn H et al (1991) Immunotherapy with cat-and dog-dander extracts. V. Effects of 3 years of treatment. J Allergy Clin Immunol 87(5):955-964
16. Ewbank PA, Murray J, Sanders K et al (2003) A double-blind, placebo-controlled immunotherapy dose-response study with standardized cat extract. J Allergy Clin Immunol 111 (1):155-161 (Pubitemid 36143307)
17. Nanda A, O'connor M, Anand M et al (2004) Dose dependence and time course of the immunologic response to administration of standardized cat allergen extract. J Allergy Clin Immunol 114(6):1339-1344 (Pubitemid 39575887)
18. Lilja G, Sundin B, Graff-Lonnevig V et al (1989) Immunotherapy with cat-and dog-dander extracts. IV. Effects of 2 years of treatment. J Allergy Clin Immunol 83(1):37-44 (Pubitemid 19052812)
19. Sundin B, Lilja G, Graff-Lonnevig V et al (1986) Immunotherapy with partially purified and standardized animal dander extracts. I. Clinical results from a double-blind study on patients with animal dander asthma. J Allergy Clin Immunol 77(3):478-487 (Pubitemid 16135701)
20. Esch RE, Bush RK, Peden D, Lockey RF (2008) Sub-lingual-oral administration of standardized allergenic extracts: phase 1 safety and dosing results. Ann Allergy Asthma Immunol 100(5):475-481 (Pubitemid 351668785)
21. Nelson HS, Oppenheimer J, Vatsia GA, Buchmei-er A (1993) A double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized cat extract. J Allergy Clin Immunol 92(2):229-236 (Pubitemid 23254111)
22. Oppenheimer J, Areson JG, Nelson HS (1994) Safety and efficacy of oral immunotherapy with standardized cat extract. J Allergy Clin Immunol 93(1 Pt 1):61-67
23. Sanchez PA, Schamann F, Garcia JA (2001) Sublingual immunotherapy with cat epithelial extract. Personal experience. Allergol Immunopathol (Madr) 29(2):60-65 (Pubitemid 32452446)
24. Alvarez-Cuesta E, Berges-Gimeno P, Gonzalez-Mancebo E et al (2007) Sublingual immunotherapy with a standardized cat dander extract: evaluation of efficacy in a double blind placebo controlled study. Allergy 62(7):810-817 (Pubitemid 46934367)
25. Norman PS, Ohman JLJr, Long AA et al (1996) Treatment of cat allergy with T-cell reactive peptides. Am J Respir Crit Care Med 154(6 Pt 1):1623-1628 (Pubitemid 26424925)
26. Maguire P, Nicodemus C, Robinson D et al (1999) The safety and efficacy of ALLERVAX CAT in cat allergic patients. Clin Immunol 93(3):222-231
27. Pene J, Desroches A, Paradis L et al (1998) Immunotherapy with Fel d 1 peptides decreases IL-4 release by peripheral blood T cells of patients allergic tocats. J Allergy Clin Immunol 102(4Pt 1):571-578 (Pubitemid 28487932)
28. Simons FE, Imada M, Li Y et al (1996) Feld 1 peptides: effect on skin tests and cytokine synthesis in cat-allergic human subjects. Int Immunol 8(12):1937-1945 (Pubitemid 27007744)
29. Worm M, Lee HH, Kleine-Tebbe J et al (2011) Development and preliminary clinical evaluation of a peptide immunotherapy vaccine for cat allergy. J Allergy Clin Immunol 127(1):89-97,97
30. Schmitz N, Dietmeier K, Bauer M et al (2009) Displaying Fel d1 on virus-like particles prevents re-actogenicity despite greatly enhanced immuno-genicity: a novel therapy for cat allergy. J Exp Med 206(9):1941-1955
31. Gronlund H, Vrtala S, Wiedermann U et al (2002) Carbohydrate-based particles: a new adjuvant for allergen-specific immunotherapy. Immunology 107(4):523-529 (Pubitemid 36693658)
32. Neimert-Andersson T, Thunberg S, Swedin L et al (2008) Carbohydrate-based particles reduce allergic inflammation in a mouse model for cat allergy. Allergy 63(5):518-526 (Pubitemid 351490401)
33. Valenta R, Niespodziana K, Focke-Tejkl M et al (2011) Recombinant allergens: What does the future hold? J Allergy Clin Immunol 127(4):860-864